Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised controlled trial'

被引：0
|
作者：
de Wolff, Liseth [1 ]
Arends, Suzanne [1 ]
Verstappen, Gwenny M. [1 ]
Vissink, Arjan [2 ]
Kroese, Frans G. M. [1 ]
Bootsma, Hendrika [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen 30 001, NL-9700 Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Oral & Maxillofacial Surg, Groningen, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷 / 06期
关键词：
Sjogren's syndrome; therapeutics; outcome assessment; health care;
D O I：
10.1136/annrheumdis-2021-220198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E148 / E148
页数：1
相关论文
共 50 条
  • [1] Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'
    Wang, Bin
    Chen, Shiju
    Xuan, Jingxiu
    Li, Yan
    Zheng, Qing
    Zhang, Xinwei
    Liu, Yuan
    Shi, Guixiu
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03)
  • [2] Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial
    Felten, Renaud
    Devauchelle-Pensec, Valerie
    Seror, Raphaele
    Duffau, Pierre
    Saadoun, David
    Hachulla, Eric
    Yves, Hatron Pierre
    Salliot, Carine
    Perdriger, Aleth
    Morel, Jacques
    Mekinian, Arsene
    Vittecoq, Olivier
    Berthelot, Jean-Marie
    Dernis, Emanuelle
    Le Guern, Veronique
    Dieude, Philippe
    Larroche, Claire
    Richez, Christophe
    Martin, Thierry
    Zarnitsky, Charles
    Blaison, Gilles
    Kieffer, Pierre
    Maurier, Francois
    Dellal, Azeddine
    Rist, Stephanie
    Andres, Emmanuel
    Contis, Anne
    Chatelus, Emmanuel
    Sordet, Christelle
    Sibilia, Jean
    Arnold, Cecile
    Tawk, Mira Y.
    Aberkane, Ouafaa
    Holterbach, Lise
    Cacoub, Patrice
    Saraux, Alain
    Mariette, Xavier
    Meyer, Nicolas
    Gottenberg, Jacques-Eric
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 329 - 338
  • [3] Response to: 'Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'' by Wang et al
    Felten, Renaud
    Gottenberg, Jacques-Eric
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03)
  • [4] Response to: 'Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'' by de Wolff et al
    Felten, Renaud
    Gottenberg, Jacques-Eric
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E149 - E149
  • [5] Interleukin-1 Inhibition and Fatigue in Primary Sjogren's Syndrome - A Double Blind, Randomised Clinical Trial
    Norheim, Katrine Braekke
    Harboe, Erna
    Goransson, Lasse G.
    Omdal, Roald
    PLOS ONE, 2012, 7 (01): : 429 - 435
  • [6] Rituximab treatment in primary Sjogren's syndrome: A double-blind placebo controlled trial
    Meijer, Jiska M.
    Vissink, Arjan
    Meiners, Petra M.
    Spijkervet, Fred K. L.
    Kallenberg, Cees G. M.
    Bootsma, Hendrika
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S430 - S431
  • [7] Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomised controlled trial
    Meurin, P.
    Lelay-Kubas, S.
    Pierre, B.
    Pereira, H.
    Pavy, B.
    Iliou, M. C.
    Bussiere, J. L.
    Weber, H.
    Beugin, J. P.
    Farrokhi, T.
    Bellemain-Appaix, A.
    Briota, L.
    Tabet, J. Y.
    HEART, 2015, 101 (21) : 1711 - 1716
  • [8] Effect of Interleukin-6 Receptor Inhibition with Tocilizumab in Patients With Rheumatoid Arthritis (OPTION Study): A Double-Blind, Placebo-Controlled, Randomised Trial
    Dejaco, C.
    Duftner, C.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (02): : 101 - +
  • [9] Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
    Smolen, Josef S.
    Beaulieu, Andre
    Rubbert-Roth, Andrea
    Ramos-Remus, Cesar
    Rovensky, Josef
    Alecock, Emma
    Woodworth, Thasia
    Alten, Rieke
    LANCET, 2008, 371 (9617): : 987 - 997
  • [10] Hydroxychloroquine for Sjogren's syndrome: A double-blind placebo controlled pilot trial
    Pillemer, SR
    Pando, J
    Magno, B
    Kurrasch, R
    Atkinson, J
    Macynski, A
    Fox, P
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1035 - 1035
12345